Shionogi Seiyaku KK
4507
ISIN JP3347200002 / Valor 763280
Shionogi Seiyaku KK
UMushroom community rating:
About company
Shionogi Seiyaku KK is a pharmaceutical company focused on drug discovery and the development of innovative healthcare products and services. The company collaborates with a variety of partners to address social issues and healthcare needs, aiming to enhance its corporate value and contribute meaningfully to society. Shionogi's business strategy emphasizes the creation of new medical solutions and the delivery of value to its stakeholders, including patients, healthcare providers, and partners. The company is committed to growth and development, leveraging its strengths in pharmaceutical research and development to bring effective treatments to market.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (14.08.2024):
Revenue Growth
Shionogi Seiyaku KK reported a revenue of 435,081 million yen for the fiscal year ending March 31, 2024, reflecting a 2.0% increase compared to the previous fiscal year. This growth was driven by strong sales performance across various segments.
Operating Profit
The company achieved an operating profit of 153,310 million yen for the fiscal year ending March 31, 2024. This represents a 2.9% increase from the previous year, indicating improved operational efficiency and cost management.
Profit Before Tax
Shionogi Seiyaku KK's profit before tax for the fiscal year ending March 31, 2024, was 198,283 million yen, marking a 10.0% decrease from the previous fiscal year. This decline was primarily due to increased investment in research and development.
Dividends
The company declared an annual dividend of 160.00 yen per share for the fiscal year ending March 31, 2024, up from 135.00 yen per share in the previous year. This increase reflects Shionogi Seiyaku KK's commitment to returning value to its shareholders.
Financial Outlook
For the fiscal year ending March 31, 2025, Shionogi Seiyaku KK forecasts a revenue of 455,000 million yen, representing a 4.6% increase. The company also projects a profit before tax of 160,000 million yen, indicating a 4.4% growth, driven by anticipated market expansion and new product launches.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
13237 M
Market cap (USD)
899,800
Daily traded volume (Shares)
6400 / 6241
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
